VBA
GMED icon

Van Berkom & Associates’s Globus Medical GMED Stock Holding History

Van Berkom & Associates’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,333,111
Closed -$76.3M – 71
2025
Q3 		$76.3M Buy
1,333,111
+48,906
+4% +$2.82M 2.21% 22
2025
Q2 		$75.8M Buy
1,284,205
+165,773
+15% +$10.7M 2.26% 23
2025
Q1 		$81.9M Sell
1,118,432
-68,894
-6% -$5.69M 2.63% 13
2024
Q4 		$98.2M Sell
1,187,326
-265,332
-18% -$20.9M 2.92% 7
2024
Q3 		$104M Sell
1,452,658
-28,401
-2% -$2M 2.85% 10
2024
Q2 		$101M Sell
1,481,059
-61,292
-4% -$3.66M 3.03% 7
2024
Q1 		$82.7M Sell
1,542,351
-34,589
-2% -$1.86M 2.36% 20
2023
Q4 		$84M Buy
1,576,940
+127,553
+9% +$6.22M 2.44% 16
2023
Q3 		$72M Buy
1,449,387
+275,252
+23% +$15.4M 2.34% 19
2023
Q2 		$69.9M Buy
1,174,135
+25,655
+2% +$1.46M 2.54% 13
2023
Q1 		$65M Buy
1,148,480
+338,535
+42% +$21.7M 2.41% 13
2022
Q4 		$60.2M Sell
809,945
-41,855
-5% -$2.85M 2.58% 12
2022
Q3 		$50.7M Sell
851,800
-34,122
-4% -$2.05M 2.41% 14
2022
Q2 		$49.7M Buy
885,922
+45,974
+5% +$3.02M 2.08% 29
2022
Q1 		$62M Sell
839,948
-89,908
-10% -$6.25M 2.22% 20
2021
Q4 		$67.1M Sell
929,856
-17,141
-2% -$1.24M 1.98% 30
2021
Q3 		$72.6M Sell
946,997
-197,299
-17% -$15.8M 2.2% 24
2021
Q2 		$88.7M Sell
1,144,296
-330,403
-22% -$23.5M 2.44% 15
2021
Q1 		$90.9M Sell
1,474,699
-97,604
-6% -$6.18M 1.99% 26
2020
Q4 		$103M Sell
1,572,303
-10,056
-0.6% -$578K 2.35% 22
2020
Q3 		$78.4M Sell
1,582,359
-9,905
-0.6% -$511K 2.27% 21
2020
Q2 		$76M Buy
1,592,264
+11,380
+0.7% +$549K 2.23% 25
2020
Q1 		$67.2M Buy
1,580,884
+115,589
+8% +$5.71M 2.41% 18
2019
Q4 		$86.3M Sell
1,465,295
-63,641
-4% -$3.46M 2.33% 19
2019
Q3 		$78.2K Buy
1,528,936
+52,241
+4% +$2.49M 1.92% 19
2019
Q2 		$62.5M Buy
1,476,695
+137,561
+10% +$5.97M 1.81% 32
2019
Q1 		$66.2M Buy
1,339,134
+82,705
+7% +$3.74M 2.1% 21
2018
Q4 		$54.4M Buy
1,256,429
+21,793
+2% +$1.09M 1.92% 28
2018
Q3 		$70.1M Sell
1,234,636
-26,996
-2% -$1.42M 1.99% 22
2018
Q2 		$63.7M Sell
1,261,632
-124,218
-9% -$6.48M 1.85% 31
2018
Q1 		$69M Sell
1,385,850
-131,416
-9% -$6.18M 2.09% 21
2017
Q4 		$62.4M Sell
1,517,266
-325,035
-18% -$11.4M 2.03% 23
2017
Q3 		$54.8M Sell
1,842,301
-133,959
-7% -$4.09M 1.97% 24
2017
Q2 		$65.5M Buy
1,976,260
+4,640
+0.2% +$146K 2.37% 14
2017
Q1 		$58.4M Sell
1,971,620
-175,290
-8% -$4.78M 2.19% 20
2016
Q4 		$53.3M Sell
2,146,910
-40,740
-2% -$926K 2.14% 19
2016
Q3 		$49.4M Buy
2,187,650
+85,620
+4% +$2.01M 2.1% 25
2016
Q2 		$50.1M Sell
2,102,030
-38,923
-2% -$934K 2.29% 18
2016
Q1 		$50.8M Buy
2,140,953
+103,185
+5% +$2.52M 2.31% 15
2015
Q4 		$56.7M Buy
2,037,768
+64,242
+3% +$1.61M 2.8% 7
2015
Q3 		$40.8M Buy
1,973,526
+165,070
+9% +$4.18M 2.04% 26
2015
Q2 		$46.4M Buy
1,808,456
+24,710
+1% +$626K 2.2% 19
2015
Q1 		$45M Buy
1,783,746
+292,889
+20% +$7.14M 2.05% 27
2014
Q4 		$35.4M Buy
1,490,857
+278,462
+23% +$6.17M 1.71% 37
2014
Q3 		$23.8M Buy
+1,212,395
New +$24.9M 1.19% 43

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Van Berkom & Associates's GMED Position: Q4 2025 in Review

Van Berkom & Associates sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 1,333,111 shares — an estimated $76.3M sold.

Van Berkom & Associates first reported a position in GMED in Q3 2014 and held it in 45 quarters. The position peaked at $104M in Q3 2024. 561 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Van Berkom & Associates reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Van Berkom & Associates sold 1,333,111 Globus Medical shares in Q4 2025, an estimated $76.3M.
  • Van Berkom & Associates first reported a position in Globus Medical in Q3 2014 and held it in 45 quarters.
  • Van Berkom & Associates's Globus Medical position peaked at $104M in Q3 2024.
  • 561 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Van Berkom & Associates's 13F filing for Q4 2025, filed 2 Feb 2026.